Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:334-342, doi:10.1016/j.jacc.2008.12.082
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Google Scholar
Right arrow Articles by Arimura, T.
Right arrow Articles by Kimura, A.
PubMed
Right arrow Articles by Arimura, T.
Right arrow Articles by Kimura, A.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: GENETICS/GENOMICS

Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy

Takuro Arimura, DVM, PhD*, J. Martijn Bos, MD{dagger}, Akinori Sato, MD*, Toru Kubo, MD, PhD{ddagger}, Hiroshi Okamoto, MD, PhD§, Hirofumi Nishi, MD, PhD||, Haruhito Harada, MD, PhD, Yoshinori Koga, MD, PhD, Mousumi Moulik, MD#, Yoshinori L. Doi, MD, PhD{ddagger}, Jeffrey A. Towbin, MD**, Michael J. Ackerman, MD, PhD{dagger} and Akinori Kimura, MD, PhD{dagger}{dagger},*

* Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
{dagger} Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota
{ddagger} Department of Medicine and Geriatrics, Kochi Medical School, Kochi, Japan
§ Division of Cardiovascular Medicine, Nishi Sapporo National Hospital, Sapporo, Japan
|| Nishi Hospital, Omuta, Japan
Division of Cardiovascular Disease, Kurume University Medical Center, Kurume, Japan
# Department of Pediatrics, Division of Cardiology, University of Texas Medical School Houston, Houston, Texas
** Heart Institute, Department of Pediatrics and Pediatric Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
{dagger}{dagger} Laboratory of Genome Diversity, School of Biomedical Science, Tokyo Medical and Dental University, Tokyo, Japan

Manuscript received August 21, 2008; revised manuscript received November 20, 2008, accepted December 3, 2008.

* Reprint requests and correspondence: Dr. Akinori Kimura, Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Bunkyo-Ku, Tokyo 113-8510, Japan (Email: akitis{at}mri.tmd.ac.jp).

Objectives: The purpose of this study was to explore a novel disease gene for hypertrophic cardiomyopathy (HCM) and to evaluate functional alterations caused by mutations.

Background: Mutations in genes encoding myofilaments or Z-disc proteins of the cardiac sarcomere cause HCM, but the disease-causing mutations can be found in one-half of the patients, indicating that novel HCM-susceptibility genes await discovery. We studied a candidate gene, ankyrin repeat domain 1 (ANKRD1), encoding for the cardiac ankyrin repeat protein (CARP) that is a Z-disc component interacting with N2A domain of titin/connectin and N-terminal domain of myopalladin.

Methods: We analyzed 384 HCM patients for mutations in ANKRD1 and in the N2A domain of titin/connectin gene (TTN). Interaction of CARP with titin/connectin or myopalladin was investigated using coimmunoprecipitation assay to demonstrate the functional alteration caused by ANKRD1 or TTN mutations. Functional abnormalities caused by the ANKRD1 mutations were also examined at the cellular level in neonatal rat cardiomyocytes.

Results: Three ANKRD1 missense mutations, Pro52Ala, Thr123Met, and Ile280Val, were found in 3 patients. All mutations increased binding of CARP to both titin/connectin and myopalladin. In addition, TTN mutations, Arg8500His, and Arg8604Gln in the N2A domain were found in 2 patients, and these mutations increased binding of titin/connectin to CARP. Myc-tagged CARP showed that the mutations resulted in abnormal localization of CARP in cardiomyocytes.

Conclusions: CARP abnormalities may be involved in the pathogenesis of HCM.

Key Words: hypertrophic cardiomyopathy • mutation • Z-disc • cardiac ankyrin repeat protein • titin/connectin

Abbreviations and Acronyms
  Ab = antibody
  ANKRD1 = ankyrin repeat domain 1
  CARP = cardiac ankyrin repeat protein
  cDNA = complementary deoxyribonucleic acid
  Co-IP = coimmunoprecipitation
  DAPI = 4'6-diamidino-2-phenylindole
  DCM = dilated cardiomyopathy
  HCM = hypertrophic cardiomyopathy
  PCR = polymerase chain reaction
  WT = wild type


Related Articles

Phenotypic Heterogeneity of Sarcomeric Gene Mutations: A Matter of Gain and Loss?
Luisa Mestroni
J. Am. Coll. Cardiol. 2009 54: 343-345. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A28. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Mestroni
Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 343 - 345.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement